Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection

被引:100
作者
Klenerman, P
Phillips, RE
Rinaldo, CR
Wahl, LM
Ogg, G
May, RM
McMichael, AJ
Nowak, MA
机构
[1] UNIV OXFORD,DEPT ZOOL,OXFORD OX1 3PS,ENGLAND
[2] JOHN RADCLIFFE HOSP,NUFFIELD DEPT MED,MOL IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND
[3] UNIV OXFORD,DEPT ZOOL,OXFORD OX1 3PS,ENGLAND
基金
英国惠康基金;
关键词
virus dynamics; mathematical model; antiviral treatment; immune response;
D O I
10.1073/pnas.93.26.15323
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To understand the role of the immune system in limiting HIV type 1 replication, it is critical to know to what extent the rapid turnover of productively infected cells is caused by viral cytopathicity or by immune-mediated lysis. We show that uncultured peripheral blood mononuclear cells of many patients contain cytotoxic T lymphocytes (CTL) that lyse target cells--at plausible peripheral blood mononuclear cell-to-target ratios--with half-lives of less than 1 day. In 23 patients with CD4 counts ranging from 10 to 900 per mu, the average rate of CTL-mediated lysis corresponds to a target cell half-life of 0.7 day. We develop mathematical models to calculate the turnover rate of infected cells subjected to immune-mediated lysis and viral cytopathicity and to estimate the fraction of cells that are killed by CTL as opposed to virus. The models provide new interpretations of drug treatment dynamics and explain why the observed rate of virus decline is roughly constant for different patients. We conclude that in HIV type 1 infection, CTL-mediated lysis can reduce virus load by limiting virus production, with small effects on the half-life of infected cells.
引用
收藏
页码:15323 / 15328
页数:6
相关论文
共 44 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] HIV SUPPRESSION BY INTERLEUKIN-16
    BAIER, M
    WERNER, A
    BANNERT, N
    METZNER, K
    KURTH, R
    [J]. NATURE, 1995, 378 (6557) : 563 - 563
  • [4] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [5] BUSEYNE F, 1993, J IMMUNOL, V150, P3569
  • [6] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [7] HIV AND T-CELL EXPANSION IN SPLENIC WHITE PULPS IS ACCOMPANIED BY INFILTRATION OF HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
    CHEYNIER, R
    HENRICHWARK, S
    HADIDA, F
    PELLETIER, E
    OKSENHENDLER, E
    AUTRAN, B
    WAINHOBSON, S
    [J]. CELL, 1994, 78 (03) : 373 - 387
  • [8] CLERICI M, 1991, J IMMUNOL, V146, P2214
  • [9] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS
    COCCHI, F
    DEVICO, AL
    GARZINODEMO, A
    ARYA, SK
    GALLO, RC
    LUSSO, P
    [J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815
  • [10] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489